CCL5 and ischemia: In many clinical situations, including atherosclerosis, stroke and myocardial IRI, RANTES has been demonstrated to play a dominant role in infiltrating inflammatory cells and concomitantly promotes the release of other inflammatory cytokines in the site of post-ischemia inflammatory injury7, 8, 9, 10, 11.